Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.710
-0.020 (-1.16%)
At close: Sep 25, 2026, 4:00 PM EDT
1.700
-0.010 (-0.58%)
After-hours: Sep 25, 2026, 7:30 PM EDT
Cardiol Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
18
Market Cap
200.79M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 78.76K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Emergent BioSolutions | 770.20M |
| Organogenesis Holdings | 457.45M |
| Aurora Cannabis | 221.16M |
| Akebia Therapeutics | 219.06M |
| Organigram Global | 217.71M |
| Lifecore Biomedical | 129.46M |
| Anika Therapeutics | 120.65M |
| ADC Therapeutics | 79.58M |
CRDL News
- 4 days ago - Cardiol Therapeutics achieves enrollment target for Phase III MAVERIC trial - TheFly
- 4 days ago - Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™'s Efficacy - PRNewsWire
- 10 days ago - Cardiol Therapeutics (CRDL) Raises $7M via Warrants, Extends Runway into 2028 - GuruFocus
- 10 days ago - Cardiol Therapeutics Registration statement: Registration filing - Filings
- 11 days ago - Cardiol Therapeutics receives over $7M in proceeds from warrant exercise - TheFly
- 11 days ago - Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds - PRNewsWire
- 12 days ago - Cardiol Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 16 days ago - Cardiol Therapeutics files $150M preliminary base shelf prospectus - TheFly